Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Stavros Konstantinides, Sylwia Sławek-Szmyt, José M Montero-Cabezas ,et al Start date: Dec 04, 2025
STORM-PE: Novel Data Driving Change in PE TreatmentJoin us for an exclusive webinar chaired by Prof Konstantinides (Mainz, DE), offering a focused exploration of advanced treatment strategies for intermediate-high and high-risk pulmonary embolism (PE). Together with leading experts Dr Montero-Cabezas (Leiden, NL), Dr Iannaccone (Turin, IT) and Dr Sławek-Szmyt (Poznan, PL), this session will… View more
Author(s): Stavros Konstantinides , José M Montero-Cabezas , Mario Iannaccone , et al Added: 6 months ago
This expert-led, on-demand programme explores the latest evidence and interventional strategies for intermediate-high and high-risk pulmonary embolism (PE). Chaired by Prof Stavros Konstantinides (University of Mainz, Mainz, DE) and featuring renowned specialists Dr José Montero-Cabezas (Leiden University Medical Center, Leiden, NL), Dr Mario Iannaccone (Turin Nord Emergency Hospital, Turin, IT)… View more
Author(s): Divaka Perera Added: 2 months ago
ACC 2026 — Prof Divaka Perera (Guy's & St Thomas' Hospital and King's College London, UK) joins us to discuss findings from the CHIP-BCIS3 trial, examining the role of percutaneous left ventricular unloading in patients undergoing high-risk coronary intervention.This phase 3 randomised controlled trial enrolled 300 patients with severe left ventricular dysfunction and extensive coronary artery… View more
Added: 6 months ago Source:  Radcliffe Cardiology
An artificial intelligence (AI) algorithm can identify high-risk coronary plaques on optical coherence tomography (OCT) images and predict adverse outcomes, according to findings from the PECTUS-AI study.¹ The research suggests that AI-assisted analysis of the entire imaged vessel provides superior prognostic value compared to manual analysis of a target lesion alone.Coronary thin-cap… View more
Author(s): Michael J Reardon Added: 1 year ago
ACC 2025 - EVOLUT Low-Risk findings show the Medtronic TAVR system is a safe and effective treatment for aortic stenosis vs surgical valves at five years.Dr Michael Reardon (Houston Methodist, Texas, US) joins us onsite at ACC to discuss the EVOLUT Low Risk trial (NCT02701283; Medtronic Cardiovascular), investigating the safety and effectiveness of the Medtronic TAVR system compared to surgical… View more
Author(s): Rahul Aggarwal , Dirk Müller-Wieland Added: 8 months ago
Filmed onsite at EASD 2025, this on-demand series features key insights from Prof Dirk Müller-Wieland and Dr Rahul Aggarwal to interpret the latest data on eicosapentaenoic acid(EPA), including the latest sub-analysis of the REDUCE-IT trial, whichanalysed the effectiveness of icosapent ethyl (IPE) on CV risk by triglyceride-glucose (TyG) index - an indicator of insulin resistance and risk of type… View more
Author(s): Ankur Kalra , Nicolas M Van Mieghem , Roxana Mehran Added: 2 months ago
In this special TIO Congress edition of Parallax, Dr Ankur Kalra is joined by two of interventional cardiology's most influential voices: Professor Roxana Mehran, incoming President of the American College of Cardiology and Co-Course Director of TIO, and Professor Nicholas Van Mieghem, TIO Course Director. The conversation spans the evolution of online medical education, sex-specific differences… View more
Added: 9 months ago Source:  Transcatheter Academy
A large-scale meta-analysis suggests that for patients with severe symptomatic aortic stenosis (AS) at a low- to intermediate-surgical risk, transcatheter aortic valve implantation (TAVI) is associated with a lower risk of all-cause death or any stroke at one year compared with surgical aortic valve replacement (SAVR).¹This study was an individual participant data (IPD) meta-analysis of four… View more